FWF Weave Programme | STAT5B Mutations from Hematopoietic Origin to Disease | Austrian Science Fund (FWF) | 2026–2029 | PI: Dr. Dagmar Gotthardt; Dr. Branko Cirovic, Prof. Stephan Ehl; https://www.fwf.ac.at/en/research-radar/10.55776/PIN1502125 FWF Stand-Alone Project | INK4a and ARF in Natural Killer Cells | Austrian Science Fund (FWF) | 2025–2029 | PI: Dr. Dagmar Gotthardt; https://www.fwf.ac.at/forschungsradar/10.55776/PAT6899224 Fellinger Cancer Research Grant | The Role of Senescence in the Transformation of Natural Killer Cells | Fellinger Cancer Research | 2024–2026 | PI: Dr. Dagmar Gotthardt; https://www.fellinger-krebsforschung.at/fellinger_forschung/2024.html GFF Lower Austria Research Grant (co-applicant) | New Checkpoints in Natural Killer Cells to Prevent Breast Cancer Metastasis | Gesellschaft für Forschungsförderung Niederösterreich (GFF) | 2022–2025 | Co-PI: Dr. Dagmar Gotthardt; Joint programme with the groups of Dr. Agnieszka Witalisz-Siepracka and Sonia Vallet (Karl Landsteiner University) https://www.gff-noe.at/forschungsfoerderung/details/GLF21-1-010/index.php?lang=EN

FWF Young Independent Researcher Group (co-applicant) | Establishing a Research Platform for the Preclinical Development of Peptide Drug Candidates | Austrian Science Fund (FWF) | 2020–2025 | PI: Dr. Dagmar Gotthardt; Joint programme with the group of Dr. Roland Hellinger (MUW), Dr. Tim Hendrikx (MUW), Dr. Kirtikumar Jadhav (University of Vienna), Dr. Eva Maria Plessl (University of Vienna) https://www.fwf.ac.at/en/research-radar/10.55776/ZK81 Fellinger Cancer Research Grant | The Role of Mutant STAT5B in Natural Killer Cells | Fellinger Cancer Research | 2020–2022 | PI: Dr. Dagmar Gotthardt; https://www.fellinger-krebsforschung.at/fellinger_forschung/2020.html City of Vienna Research Grant | The Role of Natural Killer Cell Evasion in Triple-Negative Breast Cancer | City of Vienna | 2020–2022 | PI: Dr. Dagmar Gotthardt

Vetmeduni: Grants

Pharmacology and Toxicology

Research groups

Group Gotthardt - Immune Aging & Immunotherapy

Grants

FWF Weave Programme | STAT5B Mutations from Hematopoietic Origin to Disease | Austrian Science Fund (FWF) | 2026–2029 | PI: Dr. Dagmar Gotthardt; Dr. Branko Cirovic, Prof. Stephan Ehl;
https://www.fwf.ac.at/en/research-radar/10.55776/PIN1502125
FWF Stand-Alone Project | INK4a and ARF in Natural Killer Cells | Austrian Science Fund (FWF) | 2025–2029 | PI: Dr. Dagmar Gotthardt;
https://www.fwf.ac.at/forschungsradar/10.55776/PAT6899224
Fellinger Cancer Research Grant | The Role of Senescence in the Transformation of Natural Killer Cells | Fellinger Cancer Research | 2024–2026 | PI: Dr. Dagmar Gotthardt;
https://www.fellinger-krebsforschung.at/fellinger_forschung/2024.html
GFF Lower Austria Research Grant (co-applicant) | New Checkpoints in Natural Killer Cells to Prevent Breast Cancer Metastasis | Gesellschaft für Forschungsförderung Niederösterreich (GFF) | 2022–2025 | Co-PI: Dr. Dagmar Gotthardt; Joint programme with the groups of Dr. Agnieszka Witalisz-Siepracka and Sonia Vallet (Karl Landsteiner University)
https://www.gff-noe.at/forschungsfoerderung/details/GLF21-1-010/index.php?lang=EN

FWF Young Independent Researcher Group (co-applicant) | Establishing a Research Platform for the Preclinical Development of Peptide Drug Candidates | Austrian Science Fund (FWF) | 2020–2025 | PI: Dr. Dagmar Gotthardt; Joint programme with the group of Dr. Roland Hellinger (MUW), Dr. Tim Hendrikx (MUW), Dr. Kirtikumar Jadhav (University of Vienna), Dr. Eva Maria Plessl (University of Vienna)
https://www.fwf.ac.at/en/research-radar/10.55776/ZK81
Fellinger Cancer Research Grant | The Role of Mutant STAT5B in Natural Killer Cells | Fellinger Cancer Research | 2020–2022 | PI: Dr. Dagmar Gotthardt;
https://www.fellinger-krebsforschung.at/fellinger_forschung/2020.html
City of Vienna Research Grant | The Role of Natural Killer Cell Evasion in Triple-Negative Breast Cancer | City of Vienna | 2020–2022 | PI: Dr. Dagmar Gotthardt

To the Top